JR
Distinguished in Metastatic Brain Tumor
Check Dr. Jeffrey J. Raizer's experience treating your condition:
About Dr. Jeffrey J. Raizer

Jeffrey Raizer is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Raizer has been practicing medicine for over 32 years and is rated as a Distinguished expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Transplant. He is licensed to treat patients in Illinois. Raizer is currently accepting new patients.

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 19 clinical trials in the past 15 years. In particular, he has co-authored 12 articles in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Jeffrey J. Raizer it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
675 N Saint Clair St, Chicago, IL 60611
Background & Education
Graduate Institution
New York Medical College, 1991
Specialties
Hematology Oncology
Neurology
Licenses
Psychiatry & Neurology in IL
Hospital Affiliations
Northwestern Medicine Lake Forest Hospital
Northwestern Memorial Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


18 Clinical Trials

A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
A Phase II, Open Label, Clinical Trial Of Pre-Surgical and Adjuvant Treatment of Recurrent Malignant Glioma With Tremelimumab and Durvalumab (MEDI4736) Alone and in Combination to Determine Immunologic Changes From Treatment
A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Phase I Trial of Radiation Therapy Plus Temozolomide With MK-3475 in Patients With Newly Diagnosed Glioblastoma (GBM)
A Phase I/II Trial of Arsenic Trioxide and Temozolomide in Combination With Radiation Therapy for Patients With Malignant Gliomas
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas
Phase I/II Dose Escalation Trial to Assess Safety of Intrathecal Trastuzumab for the Treatment of Leptomeningeal Metastases in HER2 Positive Breast Cancer
A Phase II Trial of Bevacizumab in Patients With Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy
A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas
A Pilot Study of the Efficacy of Levetiracetam in Patients With Seizures From Brain Metastases
A Phase 1/2 Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Glioma
View 17 Less Clinical Trials -

104 Total Publications

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished